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The non-receptor tyrosine kinase Syk is mainly expressed in the hematopoietic system and plays an essential role in b2
integrin-mediated leukocyte activation. To elucidate the signaling pathway downstream of Syk during b2 integrin (CD11/
CD18)-mediated migration and extravasation of polymorphonuclear neutrophils (PMN), we generated neutrophil-like
differentiated HL-60 (dHL-60) cells expressing a fluorescently tagged Syk mutant lacking the tyrosine residue at the position
323 (Syk-Tyr
323) that is known to be required for the binding of the regulatory subunit p85 of the phosphatidylinositol 3-kinase
(PI3K) class IA. Syk-Tyr
323 was found to be critical for the enrichment of the catalytic subunit p110d of PI3K class IA as well as for
the generation of PI3K products at the leading edge of the majority of polarized cells. In accordance, the translocation of PI3K
p110d to the leading edge was diminished in Syk deficient murine PMN. Moreover, the expression of EGFP-Syk Y323F
interfered with proper cell polarization and it impaired efficient migration of dHL-60 cells. In agreement with a major role of b2
integrins in the recruitment of phagocytic cells to sites of lesion, mice with a Syk-deficient hematopoietic system demonstrated
impaired PMN infiltration into the wounded tissue that was associated with prolonged cutaneous wound healing. These data
imply a novel role of Syk via PI3K p110d signaling for b2 integrin-mediated migration which is a prerequisite for efficient PMN
recruitment in vivo.
Citation: Schymeinsky J, Then C, Sindrilaru A, Gerstl R, Jakus Z, et al (2007) Syk-Mediated Translocation of PI3Kd to the Leading Edge Controls
Lamellipodium Formation and Migration of Leukocytes. PLoS ONE 2(11): e1132. doi:10.1371/journal.pone.0001132
INTRODUCTION
The efficient recruitment of polymorphonuclear neutrophils
(PMN) to sites of lesion is critical for host defense, inflammation
and tissue repair [1,2]. An essential step during this process is
chemotactic migration which requires the presence of chemoat-
tractants and depends on adhesive cell-matrix interactions that are
mainly mediated by the leukocyte adhesion molecules of the
integrin family [3,4]. Especially, b2 integrins (CD11/CD18) are
critically involved in firm adhesion and migration of PMN [4,5].
The b2 integrins are heterodimers consisting of a common b-
subunit (CD18) which is non-covalently associated with one of the
four known a-subunits (CD11) and are named accordingly:
CD11a/CD18 (aLb2, LFA-1), CD11b/CD18 (aMb2, Mac-1,
CR3), CD11c/CD18 (aXb2, gp150/95, CR4) or CD11d/CD18
(aDb2) [5]. The pivotal role of CD18 during the acute
inflammatory response becomes obvious in patients suffering from
leukocyte adhesion deficiency type-1 (LAD-1) where a defective
CD18 expression is the cause of impaired wound healing and
recurrent bacterial infections due to a recruitment defect of PMN
[4]. Accordingly, a recent in vivo study demonstrated an impaired
adhesion of LFA-1
2/2 PMN to the wall of postcapillary venules of
the murine cremaster muscle upon stimulation with macrophage
inflammatory protein-2 (Mip-2) and a decreased intraluminal
crawling of Mac-1
-/- PNM accompanied by a delayed emigration
through nonoptimal sites [6]. Downstream signaling of CD18 via
specific Immunoreceptor Tyrosine-based Activation Motif
(ITAM)-bearing adapter proteins (i.e. DAP12 and the Fc receptor
(FcR) c-chain) leads to the activation of the non-receptor tyrosine
kinase Syk [7–9] which has been shown to be critical for migration
of neutrophil-like differentiated HL-60 cells (dHL-60) and primary
murine PMN [10,11]. Syk has several interacting signaling
partners e.g. Vav, the phophoinositide-specific phospholipase C
(PLC) isozymes PLCc-1 and PLCc-2, and Cbl which are known to
exert a functional impact on different leukocyte functions
including cell migration [10–17]. Recently, a direct interaction
between Syk and the regulatory subunit p85 of the phosphatidy-
linositol 3-kinases (PI3K) class IA has been demonstrated [13,18].
PI3Ks are grouped into three classes, I, II and III, according to
their substrate preference and structural homology [19]. Class I
PI3Ks, which produce the secondary messenger phosphatidylino-
sitol-(3,4,5)-trisphosphate (PIP3), are divided into two subgroups,
IA and IB. Class IA PI3Ks are tightly bound heterodimers that
consists of a p50–55/p85 regulatory subunit and one of the three
p110 catalytic subunits, p110a, p110b or p110d. The three
isoforms of the p85 regulatory subunit (p85a with its splice
products p55a and p50a, p85b and p55c) mediate the activation of
class IA PI3K by binding to receptor tyrosine kinases and adaptor
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p85 and recruits the p85–p110 heterodimer to its substrate at the
plasma membrane. Class IB PI3Ks are dimers consisting of the
catalytic subunit p110c and one of the regulatory subunits p101 or
p84 (p87
PIKAP) [19,20]. The PI3K signaling pathway is critically
involved in the control of PMN motility and chemotaxis [3] and b2
integrins are capable of activating PI3K in PMN [21]. In these
cells, chemoattractants can activate both the class IA PI3K as well
as the class IB PI3K, i.e. p110c which is regulated by G-protein
coupled receptor signaling [19,22]. Furthermore, a relevance of
Syk in the activation of PI3K has been described for T cell and B
cell receptor-mediated signaling and in PMN after the stimulation
with monosodium urate crystals [23–25].
In the present study, we unraveled the physiological role of Syk-
mediated translocation and activation of PI3K p110d upon
adhesion and polarization of leukocytes in the presence of the b2
integrin ligand fibrinogen. Cell polarization and migration of
dHL-60 cells expressing fluorescently tagged wildtype Syk and
a Syk mutant lacking the binding site for the p85 regulatory
subunit of PI3K Class IA (EGFP-Syk Y323F, mCherry-Syk
Y323F) were analyzed in vitro by confocal microscopy and time-
lapse video microscopy. To address the in vivo relevance of Syk-
mediated signaling for PMN recruitment to sites of lesion, we
performed a wound healing assay using wildtype mice recon-
stituted with a Syk deficient hematopoietic system.
MATERIALS AND METHODS
Reagents and antibodies
BSA, human fibrinogen, fMLP and Percoll
TM were obtained from
Sigma, Deisenhofen, Germany. Piceatannol was obtained from
Calbiochem, La Jolla, CA, USA. We purchased RPMI 1640
medium, FCS, penicillin, streptomycin and PBS from Biochrom,
Berlin, Germany. IMDM including L-Glutamine and 25 mM
HEPES was purchased from Invitrogen, Karlsruhe, Germany.
Antibodies to Syk (clone 4D10, IgG2a), p110d (H-219, sc-7176),
p110c (H-199, sc-7177), Cbl (C-15, sc-170), PLCc-1 (2R1, sc-
58408), PLCc-2 (B-10, sc-5283), or Dock2 (E-15, sc-50921) were
obtained from Santa Cruz, Santa Cruz, CA, USA. The mono-
clonal anti-CD18 antibody (clone MHM23) was purchased from
DakoCytomation, Glostrup, Denmark. Alexa fluorochrome-con-
jugated secondary antibodies and phalloidin were purchased from
Invitrogen, Karlsruhe, Germany.
cDNA contructs
The EGFP-tagged Syk Y323F mutant was obtained from the non-
mutated EGFP-Syk plasmid as described previously [10]. The
used DNA oligonucleotides 59-TGTCATTCAATCCGTTT-
GAGCCAGAACTTGG-39 and its complement reverse form
were obtained from Metabion, Martinsried, Germany. The
introduction of the expected mutation was confirmed by
automated DNA sequencing (Medigenomix, Martinsried, Ger-
many). For the expression of red fluorescent fusion proteins the
coding region of EGFP of the EGFP-C1 expressing vector
(Clontech, BD New York, USA) was replaced with a PCR-DNA
Fragment of the mCherry cDNA flanked with a NheI and a BglII
restriction site (DNA oligonucleotides: forward 59-GCTAGCGC-
CACCATGGTGAGC-AAGGGCGAG-39, and reverse 59-
CTGACAGATCTCTTGTACAGCTCGTCCATGC-39). The
mCherry cDNA was a generous gift of Dr. Roger Y. Tsien, Dept.
of Chemistry and Biochemistry, University of California at San
Diego, La Jolla, CA, USA [26]. The coding region of wildtype Syk
or Syk Y323F was cloned into the EcoRI/KpnI site of the newly
synthesized mCherry-C1 vector.
Cell culture and electroporation of dHL-60 cells
The human myeloid HL-60 cell line (ACC 3) was obtained from
the German Resource Centre for Biological Material (Braunsch-
weig, Germany). The HL-60 cell line stably expressing PH-AKT-
GFP was kindly provided by Dr. H. R. Bourne, UCSF, CA, USA
[27]. PMN-like differentiation of HL-60 cells and the electropora-
tion protocol was described previously [10]. The generation of the
HL-60 cell line stably expressing a Syk specific short hairpin RNA
which led to a reduced Syk expression via the generation of short
interfering RNA (Syk-siRNA) was generated as described [10].
Isolation of murine bone marrow PMN
Murine bone marrow PMN were isolated as described previously
[10]. Briefly, the bone marrow from femurs and tibias was isolated
and subsequently loaded on top of a discontinuous Percoll
TM
gradient (52%/64%/72%) and centrifuged at 1000 g for 30 min.
PMN were harvested from the 64%/72% interface and cultivated
for 24 h in RPMI 1640 medium supplemented with 20% of
WEHI-3B-conditioned medium. PMN viability was .95% as
assessed by the trypan blue exclusion test, purity was .98% as
analyzed by microscopy using Hemacolor
TM staining (Merck,
Darmstadt, Germany).
Functional assays and microscopy
Adhesion and migration assays and time-lapse video microscopy
was performed as described previously. Polarized dHL-60 cells
were prepared for staining and used for confocal microscopy as
described [10].
Wound-healing model
The wound healing assay was performed as described [28]. Briefly,
after anaesthetizing the mice, excisional wounds were punched at
four sites in the middle of the dorsum using 5-mm biopsy stamps
(STIEFEL, Offenbach, Germany). Each wound region was
digitally photographed at indicated time points, and areas were
calculated using photoshop software (Adobe Systems, San Jose,
CA, USA). For immunohistochemistry wound granulation tissues
were fixed in 4% neutral buffered formalin and embedded in
paraffin. Neutrophils were detected using an anti-Gr-1 antibody
(clone RB6-8C5, BD Pharmingen, Heidelberg, Germany) as
described [28]. Slides were visualized using a Zeiss Axiophot
microscope (Carl Zeiss Inc., Oberkochen, Germany) and pictures
were acquired with a digital color camera and corresponding
software (AxiocamH, Zeiss). Mice carrying the Syk
tm1Tyb (referred
to as Syk
2) mutation were maintained as Syk
+/2 heterozygotes on
the C57BL/6 genetic background [29]. The generation of mice
with a Syk
2/2 hematopoietic system was performed as described
previously [10].
Statistical analysis
Data shown represent means6SD. Statistical significance was
determined using a two-tailed Student’s t-test or the Mann-
Whitney U-test, in case of non-normal distributions. p,0.05 was
considered statistically significant.
RESULTS
Syk-Tyr
323 is required for the consolidation of the
leading edge and for efficient migration of dHL-60
cells
To characterize the CD18-mediated signaling pathway down-
stream of Syk during PMN migration and infiltration, we
Syk Controls PI3Kd in PMN
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Syk mutant (EGFP-Syk Y323F), where the major binding site of
the regulatory subunit p85 of the PI3K class IA was removed
[13,18]. As expected, EGFP-Syk expressing cells polarized upon
stimulation by 100 nM fMLP on immobilized fibrinogen and the
majority of these cells formed one lamellipodium that was
characterized by an enrichment of F-actin and CD18. However,
29.7% of the cells formed more than one lamellipodium (Figure 1A
and C). In contrast, 51.8% of the EGFP-Syk Y323F expressing
cells showed an excessive lamellipodium formation, whereas CD18
was still enriched at the leading edge. Furthermore, dHL-60 cells
expressing EGFP-Syk enriched Syk at the lamellipodium (63.4%)
which is in accordance with our previous findings (Figure 1B and
D) [10]. Similarly, 66.0% of the Syk Y323F mutants showed an
enhanced EGFP fluorescence at the lamellipodium indicating that
Syk-Tyr
323 was not required for the translocation of Syk but
involved in the consolidation of the leading edge. As the
establishment of ordered cell polarity is a prerequisite for efficient
cell migration, we performed migration assays using dHL-60 cells
expressing EGFP-Syk or EGFP-Syk Y323F. Whereas 87.4% of the
EGFP-Syk transfectants performed efficient migration on immo-
bilized fibrinogen along a gradient of 10 nM fMLP (Figure 1E and
F), this percentage was significantly reduced to 39.5% in cells
expressing the Syk mutant which again formed multiple and
unstable lamellipodia (Please see also Movie S1 and Movie S2
presented as supplemental information). These results indicate that
Syk-Tyr
323 supported the maintenance of cell polarity, a pre-
requisite for efficient cell migration suggesting that the PI3K class
IA may act downstream of Syk.
The enrichment of PI3K p110d at the leading edge
of dHL-60 cells depends on Syk-Tyr
323
The class IA PI3K p110d is predominantly expressed in leukocytes
and it is known to play an essential role in PMN chemotaxis [30–
32]. As the precise temporal and spatial distribution of activated
signal transducers is critical for the control of cell functions such as
migration [3], we analyzed the subcellular distribution of PI3K
p110d in polarized EGFP-Syk Y323F transfectants and in dHL-60
EGFP-Syk expressing control cells. Upon induction of cell
polarization on immobilized fibrinogen with a uniform concen-
tration of 100 nM fMLP, PI3K p110d staining was enriched at the
lamellipodium in 68.3% of the control cells (Figure 2A and C). In
contrast, the enrichment of PI3K p110d at the leading edge was
significantly impaired to 35.9% in the Syk mutant although an
enhanced EGFP-Syk Y323 epifluorescence similar to the control
transfectants was still detectable at the lamellipodium (66.8% and
58.0%, respectively). The finding that intact Syk was involved in
the efficient translocation of p110d to the leading edge was
confirmed using a previously described HL-60 cell clone that
downregulates Syk protein expression by stably producing a Syk
specific short-interfering RNA (Syk-siRNA) [10]. The Syk-siRNA
dHL-60 cells formed multiple lamellipodia and showed an
impaired enrichment of PI3K p110d at the leading edge in
37.0% of the cells compared to 63.0% of the wildtype cells
(Figure 2B and C). These findings confirm that Syk was required
for the observed asymmetric distribution of PI3K p110d within the
cell. Recent studies have demonstrated a critical role for PI3K
p110c in the control of PMN migration [33,34]. To ask whether
Syk-Tyr
323 is required for the translocation of PI3K p110c during
b2 integrin-mediated adhesion and polarization in leukocytes, we
analyzed the subcellular localization of PI3K p110c in EGFP-Syk
Y323F or EGFP-Syk expressing dHL-60 cells. The majority of the
polarized EGFP-Syk and EGFP-Syk Y323F expressing cells
showed not only an enrichment of EGFP epifluorescence (69.3%
and 75.1%, respectively) but also an accumulation of PI3K p110c
staining (83.2% and 78.2%) at the lamellipodium forming site
indicating that the translocation of the Class IB PI3K p100c was
independent of Syk-Tyr
323 (Figure 2D and E).
Since it is known that the adaptor protein Cbl binds to Syk-
Tyr
323 [35] and expression and tyrosine phosphorylation of Cbl
regulates macrophage chemokinetic and chemotactic movement
[17], we analyzed the EGFP-Syk transfectants and Syk-siRNA
expressing cells for the subcellular distribution of Cbl (Figure 3).
The majority of EGFP-Syk expressing control cells as well as
EGFP-Syk Y323F transfectants showed enrichment of Syk (70.2%
and 73.1%) and of Cbl (80.3% and 71.8%) at the leading edge.
Moreover, downregulation of Syk by RNAi technique did not
affect the translocation of Cbl to the leading edge indicating that
Syk-Tyr
323 as well as a certain threshold of Syk protein was not
required for the enrichment of Cbl at the lamellipodium forming
site. Thus, Syk-Tyr
323 is specifically required for accumulation of
PI3K p110d but dispensable for the enrichment of Cbl at the
leading edge. In a previous study, we have shown that Syk-Tyr
348
was indispensable for the recruitment of the guanine nucleotide
exchange factor Vav to the leading edge and the control of
leukocyte migration [10]. However, this process seems to be
independent of Syk-Tyr
323-mediated signaling, since the enrich-
ment of Vav at the leading edge was not affected in the Syk-Tyr
323
mutants (supporting information Figure S1 A and E). To
investigate whether Syk-Tyr
323 has an impact on the translocation
of other potential downstream signaling components of Syk, we
investigated the subcellular localization of dedicator of cytokinesis
2 (Dock2), PLCc-1 and PLCc-2 in dHL-60 cells expressing
wildtype Syk and the Syk mutant. Dock2, an activator of Rac and
a member of the CDM family proteins (Caenorhabditis elegans CDE-
5, mammalian Dock180 and Drosophila melanogaster Myoblast City),
has been recently described to be required for the migration and
polarization during PMN chemotaxis and its translocation to the
leading edge has been reported to depend on PI3K activity [36].
However, the translocation of all these proteins to the leading edge
did not depend on Syk-Tyr
323 (supporting information Figure S1
B–E). Thus, Syk-Tyr
323 seems to be specifically required for the
enrichment of PI3K p110d to the leading edge of polarized
leukocytes.
The spatio-temporal control of PI3K activity is
mediated by Syk-Tyr
323
To study the functional relevance of the impaired translocation of
PI3K p110d to the leading edge, we measured PI3K activity
indirectly using the PH-AKT-GFP HL-60 cell line. This cell line
constitutively expresses the pleckstrin homologous (PH) domain of
the AKT kinase fused to an EGFP tag that functions as a biosensor
for PI3K activity by binding to PI3K products in live cells [27]. In
suspended PH-AKT-GFP dHL-60 cells, Syk and PH-AKT
epifluorescence were homogenously distributed after stimulation
(Figure 4A). Upon induction of cell adhesion on immobilized
fibrinogen with 0.2 mM Mn
2+ or 100 nM fMLP, the biosensor
PH-AKT-GFP was enriched at the lamellipodium of dHL-60 cells
indicating a role of b2 integrin-mediated adhesion and signaling
for the subcellular generation of PI3K products. To analyze the
role of Syk for the activation of PI3K, we used the Syk specific
inhibitor piceatannol (Figure 4B). Upon inhibition of Syk, the cells
formed multiple lamellipodia in response to fMLP-stimulation and
showed a decreased enrichment of PH-AKT-GFP epifluorescence
at the lamellipodium (from 78.5% of the control cells to 44.7% in
the piceatannol treated cells) indicating a role of Syk for the
Syk Controls PI3Kd in PMN
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323 was required for the consolidation of the leading edge during CD18-mediated migration of dHL-60 cells. (A,B) Confocal
microscopy images of dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F stained for CD18 (A) or F-actin (B). Upon stimulation by 100 nM fMLP on
immobilized fibrinogen, all transfectants polarized and formed lamellipodia (black arrows and arrow heads), which were characterized by an
enrichment of CD18, F-actin, EGFP-Syk, or EGFP-Syk Y323 (white arrows and arrow heads). However, the expression of the Syk mutant led to the
formation of multiple lamellipodia (arrow heads). Pictures are representative of at least three independent experiments. Quantitative analysis of
microscopic images of fixed dHL-60 cells showing the percentage of cells with (C) excessive lamellipodium formation and (D) enhanced EGFP
epifluorescence at the lamellipodium (n.300 cells each, taken from at least three independent experiments). (E) Time-lapse microscopy of migrating
dHL-60 transfectants on immobilized fibrinogen in response to a gradient of 10 nM fMLP (m). Images 1–5 were recorded at intervals of 30 s. Control
transfectants migrated efficiently in contrast to Syk Y323F mutants which formed multiple, unstable lamellipodia and showed impaired migration.
The outlines of the cells at intervals of 30 s were transposed in rising grayscales to visualize cell movement. (F) Percentage of migrating dHL-60
transfectants (n=63 EGFP-Syk, n=67 EGFP-Syk Y323F) from at least four independent experiments. Data represent means6SD, bar=10 mm.
doi:10.1371/journal.pone.0001132.g001
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PI3K activity (Figure 4D). This finding is consistent with the view
that the local generation of PI3K products at the leading edge
provides a positive feedback signal that is required for the
consolidation of the leading edge [3,19]. To address specifically
the role of Syk Tyr
323 in the regulation of PI3K activity we
analyzed PH-AKT-GFP dHL-60 cells expressing fusion proteins
of wildtype Syk or the Syk Y323F mutant with the red fluorescent
reporter protein mCherry (mCherry-Syk and mCherry-Syk
Y323F, respectively). Similar to the experiments described above,
mCherry-Syk as well as PH-Akt-GFP were enriched at the leading
edge in the majority of polarized PH-Akt-GFP dHL-60 cells on
immobilized fibrinogen after the stimulation with 100 nM fMLP
(81.3% and 81.8%, respectively; Figure 4C and 4D). In
accordance with the result obtained upon pharmacological
inhibition of Syk using piceatannol the expression of mCherry-
Syk Y323F led to an impaired translocation of PH-AKT-GFP to
the lamellipodium in 49.1% of the dHL-60 cells. In contrast to the
cells expressing EGFP-Syk Y323F alone (Figure 1), cells expressing
Figure 2. Syk was required for the translocation of PI3K p110d but
not of p110c to the leading edge. Microscopy images of dHL-60 cells
expressing EGFP-Syk or EGFP-Syk Y323F (A,D) or stably expressing a Syk-
siRNA (siSyk) (B). Upon stimulation by 100 nM fMLP on immobilized
fibrinogen, PI3K p110d was enriched at the lamellipodium (arrow) of (A)
EGFP-Syk transfectants and (B) dHL-60 control cells (WT). In contrast,
dHL-60 cells expressing EGFP-Syk Y323F or Syk-siRNA (siSyk) showed an
impaired enrichment of PI3K p110d staining at the leading edge (arrow
heads). (C) Quantitative analysis of subcellular Syk and PI3K p110d
distribution using microscopic images of fixed dHL-60 cells from at least
three independent experiments. (n=67 EGFP-Syk, n=88 EGFP-Syk
Y323F; n=210 WT, n=138 Syk-siRNA). (D) PI3K p110c was translocated
to the leading edge in EGFP-Syk (arrow) as well as in EGFP-Syk Y323F
transfectants (arrow heads). (C) Quantitative analysis (n=48 EGFP-Syk,
n=49 EGFP-Syk Y323F). Data represent means6SD, bar=10 mm.
doi:10.1371/journal.pone.0001132.g002
Figure 3. The enrichment of Cbl at the lamellipodium was not
dependent on Syk-Tyr
323. Confocal microscopy images of dHL-60 cells
(A) expressing EGFP-Syk or EGFP-Syk Y323F or (B) stably expressing
a Syk-siRNA (siSyk). Upon stimulation by 100 nM fMLP on immobilized
fibrinogen, Cbl was enriched at the lamellipodium of (A) EGFP-Syk
transfectants and (B) dHL-60 control cells (arrow and arrow heads). A
similar result was obtained in dHL-60 cells expressing EGFP-Syk Y323F
or siSyk. (C) Quantitative analysis of subcellular Syk and Cbl distribution
using microscopic images of fixed dHL-60 cells taken from three
independent experiments (n=77 EGFP-Syk, n=78 EGFP-Syk Y323F;
n=177 WT, n=105 Syk-siRNA). Data represent means6SD. Bar=10 mm.
doi:10.1371/journal.pone.0001132.g003
Syk Controls PI3Kd in PMN
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attenuated enrichment of mCherry-Syk Y323 at the leading edge
which may reflect the breakdown of PI3K signaling caused by the
overexpression of PH-AKT-GFP in combination with hampered
PI3Kd signaling. However, the underlying mechanism is un-
known. Nevertheless, our results demonstrate that Syk-Tyr
323 is
involved in the complex spatio-temporal regulation of PI3K
activity.
The role of Syk in native PMN
To address the relevance of Syk for the translocation of PI3K
p110d or p100c in native PMN, we isolated and analyzed murine
PMN from the bone marrow of wildtype mice reconstituted with
a Syk-deficient or a Syk heterozygous hematopoietic system for
control. After the induction of cell polarization with 1 mM fMLP
on immobilized fibrinogen, the majority of the control cells
translocated PI3K p110d (86.3%) and PI3K p110c (84.6%) to the
leading edge (Figure 5A, B and C). In contrast, Syk deficient PMN
showed a diminished translocation of class IA PI3K p110d (41.9%)
whereas class IB PI3K p110c (75.6%) was still enriched at the
lamellipodium forming sites (Figure 5A, B and C). These findings
are in accordance with the above described results using the dHL-
60 cells and propose a selective role for Syk in the spatio-temporal
control of the class IA PI3K p110d in native murine PMN. It is
known that PI3K p110d is critically involved in the recruitment of
PMN into inflamed tissue [32]. To address the functional
relevance of Syk for PMN infiltration and wound healing in a skin
model of inflammation and repair, we produced full-thickness
excisional wounds on the back of wildtype mice reconstituted with
a Syk deficient or a Syk heterozygous hematopoietic system for
control. PMN infiltration into the wound area was analyzed 24 h
after wounding by immunostaining using the PMN specific GR-1
antibody (Figure 5A). In the wounds of mice with a Syk deficient
hematopoietic system, the number of PMN (24.264.8 PNM per
high power field) was significantly decreased compared to control
mice (96.169.5 PMN per high power field; Figure 5B). Further-
more, wound closure was significantly delayed after 10 days in WT
mice with a Syk deficient hematopoietic system to 37.0%
compared to control mice were the wound size was reduced to
17.8% of the initial wound area of 100% (Figure 5C). Thus, our
findings indicate a role of hematopoietic Syk for PMN infiltration
into the wounded tissue and for cutaneous wound healing.
DISCUSSION
PMN are the first inflammatory cells invading the wound site after
injury. Besides their defense functions against intruding micro-
organisms, PMN are an important source of signals that are
essential for the control of their own accumulation, activation and
apoptosis as well as for the attraction of macrophages and the
orchestration of tissue repair including elimination of cell debris
[1]. An essential step during PMN recruitment to sites of lesion are
the processes of intravascular crawling and of cell migration within
the tissue. PI3K signaling is known to be required for the
establishment and the maintenance of cell polarity by regulating
the subcellular localization and activation of downstream effectors
that are essential for proper chemotaxis [3,19]. Here, we show that
Syk-Tyr
323, the binding site for the regulatory subunit p85 of the
PI3K class IA, was required for the enrichment of PI3K p110d at
the lamellipodium of polarized dHL-60 cells (Figure 2 and 6). This
signaling step was critical for the consolidation and the stability of
the leading edge and for efficient migration of dHL-60 cells on
immobilized fibrinogen. This effect may be specific for class IA
PI3K since the translocation of PI3Kc was not dependent on Syk-
Figure 4. Syk activity was required for the enrichment of PI3K
products at the leading edge. Microscopy images of PH-AKT-GFP dHL-
60 cells in suspension (sus) or after induction of adhesion (ad) to
immobilized fibrinogen in the presence of 0.2 mM Mn
2+ (A), or adhered
and polarized after the induction with 100 nM fMLP (B, C). PH-AKT-GFP
dHL-60 cells were treated with 30 mM piceatannol (+Pic) or vehicle for
control (-Pic) (B), or expressed mCherry-Syk or mCherry-Syk Y323F (C).
PH-AKT-GFP dHL-60 cells stimulated in suspension did not translocate
Syk or PH-AKT-GFP (EGFP) to the membrane. In contrast, adherent cells
showed an enriched Syk staining, or mCherry-Syk and PH-AKT-GFP
epifluorescence at the lamellipodium forming site (arrow). Inhibition of
Syk or the expression of mCherry-Syk Y323F increased the population of
cells with a homogenous distribution of Syk and a diminished
concentration of PH-AKT-GFP at the lamellipodium forming site (arrow
head). Pictures are representative for at least three independent
experiments. (D) Quantitative analysis of the subcellular localization of
Syk, mCherry-Syk or mCherry-Syk Y323F (Syk LA) or PH-AKT-GFP
epifluorescence (PH LA) at the lamellipodium in PH-AKT-GFP dHL-60
cells taken from at least three experiments (n=1372Pic, n=157+Pic;
n=113 mCherry-Syk, n=99 mCherry-Syk Y323F). Data represent
means6SD. Bar=10 mm.
doi:10.1371/journal.pone.0001132.g004
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323. A requirement of PI3K p110d activity in the control of
chemotaxis has been demonstrated for human PMN in an under
agarose assay [31] and for murine PMN in a transwell assay [32].
However, random movement seemed not to be dependent on
PI3K p110d activity at least in the human system [31]. Similarly,
the inhibition of PI3K p110c has been found to induce the
formation of multiple transient lamellipodia and to inhibit
migration of dHL-60 cells on immobilized fibronectin towards
fMLP [37]. However, in this setting the pharmacological in-
hibition of PI3K p110d by using the compound IC87114 had no
effect on cell polarization and chemotaxis [37]. A reason for these
controversial findings could be that the regulation of PI3K p110d
and p110c activity may be substrate specific. This would be in
accordance with a study of Ferguson et al. showing that the
motility of PI3K p110c-deficient PMN compared to control cells
was not significantly reduced on glass, but it was significantly
impaired on surfaces to which the cells bind less tightly, namely
fibrinogen or polycarbonate [34]. However, the PMN migration
assay was conducted on immobilized fibrinogen in the present
study. In this model, PMN migration strongly depends on b2
integrins [10] and thereby reflects an inflammatory situation in
vivo where PMN migrate on fibrin within the inflamed interstitial
space.
Syk-Tyr
323 has been described to be required for the binding of
the phosphotyrosine-binding (PTB) domain of Cbl [35,38].
However, our findings suggest that this interaction is not necessary
for the translocation of Cbl to the leading edge. We have shown
previously that the Syk substrate Cbl becomes tyrosine phosphor-
ylated upon b2 integrin-mediated adhesion of human PMN
suggesting a functional link between Syk and Cbl [39].
Accordingly, a negative regulatory function of Cbl in Syk-
Tyr
323-mediated signaling has been described to be required for
the control of different biochemical pathways in B cells, e.g. for the
activation of the transcription factor NF-AT or for B cell antigen
receptor induced Ca
2+ mobilization [35,38,40], and for the control
of histamine release in mast cells [41]. Furthermore, Cbl was
involved in the recruitment of p85 to CD28 in T cells [42]. Thus,
Syk-Tyr
323 seems not to be involved in the tranlsocation of Cbl
which may not be true for the regulation of the function of Cbl.
Recently, we have reported that the redistribution of Vav
depended on Syk activity and the binding site of Vav, Syk-Tyr
348
[10]. In this study, we have shown that Syk-Tyr
323 was not
required for the translocation of Vav to the leading edge.
However, effective binding of Vav, PLCc-1 and PLCc-2, to Syk
is mediated by the phosphorylation of the Syk tyrosines Syk-Tyr
348
and Syk-Tyr
352 [13,43]. Therefore, the translocation of Vav (and
perhaps also PLCc-1 and PLCc-2) to the leading edge may be still
supported by the redistribution of Syk via b2 integrins; a process
that seems to be independent of Syk-Tyr
323. Similar to Vav, PLCc,
can be recruited to the cell membrane via its pleckstrin
homologous (PH) domain that binds the PI3K products,
PI(3,4)P2 and/or PIP3 [36,44,45]. However, our results showed
clearly that at least the activity of PI3K p110d was not required for
the enrichment of Vav and the two PLCc isoforms at the leading
edge. Since it has been described that not just the translocation but
also the enzyme activity of Vav is regulated by the lipid products of
the PI3K it is possible that Syk-Tyr
323 could play a role in the
modulation of the Vav activity at the leading edge [46]. Therefore,
Syk-Tyr
323 as well as Syk-Tyr
348 may be required for the spatio-
temporal coordination of Vav-mediated and PI3K p110d-
mediated signaling pathways, a prerequisite for efficient b2
integrin-mediated migration of PMN.
In the present study, we demonstrate that Syk activity was
required for the formation of PI3K products at the leading edge of
Figure 5. Syk was required for the enrichment of PI3K p110d at the
leading edge of murine PMN and delayed wound closure. (A,B)
Confocal microscopy images of Syk-deficient (Syk
2/2) and control
(Syk
2/+) PMN of bone marrow chimeric mice. Upon stimulation by 1 mM
fMLP on immobilized fibrinogen, PI3K p110d and PI3K p110c were
enriched at the lamellipodium (arrow) of polarized cells. In contrast,
Syk
2/2 PMN showed an impaired enrichment of PI3K p110d staining at
the leading edge (arrow heads, A) whereas PI3K p110c was still
translocated to the lamellipodium forming sites (B). Bar=10 mm. (C)
Quantitative analysis of subcellular localization of PI3K p110d and PI3K
p110c distribution using microscopic images of fixed murine PMN from
at four independent experiments. Data represent means6SD. (D) 24 h
old wound sections of wildtype mice reconstituted with a Syk
2/2 or
a Syk
+/2 hematopoietic system for control stained with the PMN
specific Gr-1 antibody (upper panel) or GR-1 antibody and DAPI (lower
panel). Control sections showed substantial infiltration of Syk
+/2 PMN
(arrows) into the wounded tissue (wm: wound margin at dotted line, es:
eschar). In contrast, Syk
2/2 PMN migration into the wounded tissue was
impaired. Scale bars, 100 mm. (E) Quantitative analysis of PMN numbers
per HPF in the wound tissue using microscopic images. (F) Wound sizes
at given time points after wounding is displayed as percentage of initial
(day 0) wound area for Syk
+/2 (#) or Syk
2/2 (m) bone marrow chimeric
mice (100%). Data represent means6SD; n=5 mice with four wounds
per animal; pday3=0.24, *pday5–10,0.001.
doi:10.1371/journal.pone.0001132.g005
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PI3K products, especially PIP3, is regulated by different feed-
forward mechanisms and is essential for the stabilization of cell
polarity [3,37]. The spatio-temporal control of PI3K p110d
activity by Syk may be involved in the amplification of migratory
signals and may be critical for the localization of this process at the
leading edge (Figure 6). In accordance with our findings, Popa-
Nita et al. have shown recently that the stimulation of human
PMN with monosodium urate crystals led to the stimulation of
class IA PI3K by a mechanism that was dependent on Syk activity
and induced the formation of a complex containing the PI3K
regulatory subunit p85 and Syk [25]. Although, the molecular
mechanism underlying the activation of PI3K and Syk was not
addressed in this study it strongly suggests a potential role of Syk-
mediated signaling via class IA PI3K in inflammatory diseases, e.g.
gout or gouty arthritis [25]. Furthermore, two recent studies have
shown that the fMLP-dependent generation of PI3K products was
bi-phasic in neutrophil-like differentiated PLB-85 cells [47] and in
murine PMN [48]. In the second phase PI3K products were
generated by PI3K p110d. This second phase was dependent on
the first phase generated by PI3K p110c indicating a functional
cross talk between Class IA and IB PI3K signaling [48].
In this study, we present evidence that hematopoietic Syk was
required for PMN recruitment to wounded tissue and for
subsequent wound healing. In accordance with these findings,
we reported previously that Syk was required for PMN adhesion
and migration in the model of the inflamed cremaster muscle in
vivo [10]. Similar in vivo effects characterized by delayed wound
closure due to impaired PMN infiltration and reduced myofibro-
blast differentiation have been described for CD18
2/2 mice [28].
Accordingly, impaired neovascularization of the granulation tissue
has been reported in CD18
2/2 mice which may imply that the
impairment of inflammation-mediated angiogenesis may contrib-
ute to poor wound healing in the absence of efficient PMN
infiltration [49]. In a human model of wounded skin, PMN have
been demonstrated to differentially express genes that are known
to be important for the modulation of the inflammatory response
of macrophages, T cells and themselves [50]. Interestingly, PMN
seem to change the responsiveness to chemotactic and immuno-
regulatory mediators once they have migrated to skin lesions and
have been activated [50]. Furthermore, the up-regulation of
different genes in PMN could play a critical role in the mediation
and regulation of processes which are critical for wound healing,
e.g. the breakdown of fibrin clots and degradation of extracellular
matrix, the promotion of angiogenesis and the migration and
proliferation of keratinocytes and fibroblasts [50]. Moreover,
CD18 has been shown to be critically involved in homing of
endothelial progenitor cells (EPC) and in neovascularization after
ischemia and reperfusion injury [51]. Two recent studies have
demonstrated a role for Syk and its substrate SLP-76 for vascular
and lymphatic development and repair, a process which critically
depended on EPC function in a cell-autonomous way [52,53] and
on integrin-mediated signaling [8]. Thus, CD18-mediated Syk
signaling seems to be of functional importance for the early
recruitment of blood-derived cells including e.g. EPC as well as
PMN into the inflamed tissue.
Figure 6. Model for localized accumulation of PI3K products at the leading edge of migrating leukocytes. Upon b2 integrin-mediated adhesion of
PMN, the ITAM-bearing adaptor proteins DAP12 and/or the FcR c-chain are phosphorylated by Src-family kinases. Syk binds to the phosphorylated
ITAM, becomes activated and enriched at the leading edge. DAP12 and the FcR c-chain are associated with different receptors, but it is unknown to
date how these receptors interact with the b2 integrin Mac-1. Here, we have shown that Syk-Tyr
323 and Syk activity were required for the recruitment
of PI3K p110d and the accumulation of PI3K products at the cell front. In contrast, the translocation of PI3K p110c to the leading edge was
independent of Syk activity and Syk-Tyr
323. Translocation and activation of PI3K p110c is mediated by GPCR-mediated signaling. Upon GPCR
activation the a-subunit of the heterotrimeric Gi protein dissociates from the receptor and the bc-subunit [22]. The bc-complex of the G protein is
known to activate PI3Kc [19,20,22]. Taken together, Syk activity and Syk-Tyr
323 mediated signaling via PI3K p110d was required for the persistent
accumulation of PI3K products at the cell front which is a prerequisite for the stabilization of the leading edge and efficient migration.
doi:10.1371/journal.pone.0001132.g006
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represent promising targets for the treatment of diverse in-
flammatory disorders that are triggered by uncontrolled innate
and adaptive immune responses [11,54]. For example, the
inhibition of PI3K p110d led to reduced PMN-mediated lung
inflammation in a murine asthma model [55]. In a previous study,
we demonstrated that Syk activity was required for efficient PMN
recruitment in two different murine models of acute inflammation,
i.e. the reverse Arthus reaction and the inflamed cremaster muscle
[10]. In accordance with our in vivo findings, a study by Puri et al.
revealed a role for PI3K p110d in mediating PMN-endothelial
interactions and PMN extravasation into the inflamed tissue [32].
Moreover, a recent study by Liu et al. demonstrated by means of
intravital microscopy that PI3K p110c and p110d have temporally
distinct roles for leukocyte recruitment into the inflamed cremaster
muscle of mice [56]. Leukocyte emigration was impaired in PI3K
p110c-deficient mice in an early response (within the first 90 min)
to the CXC chemokines MIP-2 (CXCL2) or KC (CXCL1). In
contrast, the pharmacological inhibition of PI3K p110d had no
effect on the early leukocyte recruitment but it diminished late
(after 4–5 h) chemokine-induced PMN recruitment into inflamed
tissue in vivo [56]. Taken together, we propose a novel role of Syk
for the spatio-temporal control of PI3K p110d activity during b2
integrin-mediated migration of PMN which seems to be important
for efficient PMN recruitment into the wounded tissue and
cutaneous wound closure (Figure 6).
SUPPORTING INFORMATION
Figure S1 Syk-Tyr
323 was not required for the tranlsocation of
Vav, PLCc-1, PLCc-2 and Dock2. Confocal microscopy images of
dHL-60 cells expressing EGFP-Syk or EGFP-Syk Y323F. Upon
stimulation by 100 nM fMLP on immobilized fibrinogen, Vav (A),
PLCc-1 (B), PLCc-2 (C), or Dock2 (E) were enriched at the
lamellipodium of EGFP-Syk as well as of EGFP-Syk Y323F
transfectants (arrows and arrow heads). However, PLCc-2 and
EGFP-Syk Y323F colocalization at the leading edge was absent or
weak in some lamellipodia (open arrowhead). (F) Quantitative
analysis using microscopic images of fixed dHL-60 cells were taken
from three (A,B,C) or two (D) independent experiments. Data
represent means6SD. Bar=10 mm.
Found at: doi:10.1371/journal.pone.0001132.s001 (3.74 MB TIF)
Movie S1 Time-lapse microscopy of dHL-60 cells transiently
expressing EGFP-Syk. Migration was analyzed in IBIDI-m slides
on immobilized fibrinogen in response to a gradient of 10 nM
fMLP. Images were recorded at intervals of 30 s. The movie is
representative for at least three independent experiments.
Found at: doi:10.1371/journal.pone.0001132.s002 (2.40 MB
MOV)
Movie S2 Time-lapse microscopy of dHL-60 cells transiently
expressing EGFP-Syk Y323F. Migration was analyzed in IBIDI-m
slides on immobilized fibrinogen in response to a gradient of
10 nM fMLP. Images were recorded at intervals of 30 s. The
movie is representative for at least three independent experiments.
Found at: doi:10.1371/journal.pone.0001132.s003 (2.74 MB
MOV)
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